companydata.dkcompanydata.dk

GSK 2023 ApS: Financial statements 2017

CVR: 43456415

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

GSK 2023 ApS (CVR 43456415) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -356,738 and a net result of DKK 5,057,912 compared with DKK 10,494,200 the year before. Equity in the 2017 report amounted to DKK 66,672,303. The solvency ratio was 95%.

Gross Profit
DKK -356,738
Profit/Loss
DKK 5,057,912
Equity
DKK 66,672,303
Total Assets
DKK 70,203,006
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017--357 t.5.1 mio.66.7 mio.0
2016-2.5 mio.10.5 mio.61.8 mio.0
2015-2.8 mio.5.3 mio.52.3 mio.-
2014-2.9 mio.5.7 mio.47.2 mio.-
2013-2.9 mio.3.8 mio.44.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on GSK 2023 ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

GSK 2023 ApS: The 2016 annual report is outMay 24, 2017

GSK 2023 ApS has published its annual report for 2016. Gross profit came to DKK 2,479,854, and the net result was DKK 10,494,200.

About GSK 2023 ApS

GSK 2023 ApS is a Danish company of the type Anpartsselskab based in Sæby, founded in 1972. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named B6 HOLDING A/S and B 6 AF 1972 A/S. The management consists of Brian Stenbro. The board consists of Kurt Valdemar Stenbro (chair), Brian Stenbro and Malene Stenbro. The company is owned by M.A.S.T. Holding ApS, BriSt Holding 2023 ApS and KVS Holding, Sæby ApS. The company has 2 employees (2023). In 2025, the company reported a gross profit of DKK -30,332 and a net result of DKK -5,937 compared with DKK 372,677 the year before. Equity in the 2025 report amounted to DKK 4,181,703.

Source: annual report 2025, Danish Business Authority